Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on: March 30,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on:March 30,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on: February 23,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on:February 23,2024

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on: March 06,2024

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on:March 06,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on: February 03,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on:February 03,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on: February 18,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on:February 18,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu

Updated on: January 11,2024

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu

Updated on:January 11,2024

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m

Updated on: March 05,2024

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m

Updated on:March 05,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on: January 22,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on:January 22,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on: January 07,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on:January 07,2024